Labshake search
Citations for Tocris :
351 - 400 of 948 citations for 7 Benzyloxy 3 4 dihydro 1H naphthalen 2 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2021Quote: ... 3 mM GSK3 inhibitor CHIR99021 (4953/50 Tocris), and 1,000 U/ml LIF (ESGRO ESG1107 ...
-
bioRxiv - Neuroscience 2021Quote: ... In some cases 3 mg/ml biocytin (Tocris) was added in the recording solution ...
-
bioRxiv - Neuroscience 2022Quote: ... 3) a selective PIEZO1 agonist Yoda1 (5586, Tocris). For pressure pulse stimulation ...
-
bioRxiv - Developmental Biology 2023Quote: ... N2B27 was supplemented with 3 µM CHIR99021 (Tocris), 1 µM PD0325901 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 mM L-glutamate (Glu, #0218, Tocris, UK) and 0.1 mM cyclothiazide (CTZ ...
-
bioRxiv - Bioengineering 2023Quote: ... which included 3 µM CHIR 99021 (Tocris, 4423) +/- 10 µM Y27632 (StemCell Technologies ...
-
bioRxiv - Immunology 2021Quote: In vitro tamoxifen was given as 4-hydroxytamoxifen (4-OH-Tamoxifen or OHT) (TOCRIS, Cat no. 3412) solubilized in DMSO (Life Technologies ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Systems Biology 2019Quote: ... 2μM IWP-2 (Tocris) and 10μM DAPT [goblet and enteroendocrine cells] (25).
-
bioRxiv - Neuroscience 2021Quote: ... MLi-2 (Tocris #5756) was reconstituted in DMSO to a stock concentration of 10mM ...
-
bioRxiv - Neuroscience 2022Quote: ... WIN55,212-2 (1038, Tocris), and Torin 2 (4248 ...
-
bioRxiv - Cell Biology 2020Quote: ... MLi-2 (Tocris, 5756) was used at 1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: WIN55,212-2 (Tocris, #1038), α-Humulene (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin-2 (Tocris 4248), rapamycin (CalBiochem 553211) ...
-
bioRxiv - Cell Biology 2019Quote: ... and IWP-2 (Tocris) were added at 3µM and 1µM ...
-
bioRxiv - Cell Biology 2023Quote: ... 2 µM Dorsomorphin (TOCRIS) and 2 µM XAV939 (Stemgent) ...
-
bioRxiv - Physiology 2023Quote: ... 2 μM PD0332991 (Tocris), 10 ng/ml human BDNF (Miltenyi Biotec) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 µM CHIR99021 (Tocris) and 5µM Y27632 (Santa Cruz) ...
-
bioRxiv - Neuroscience 2024Quote: ... DMH1 (2 μM, Tocris) and SB431542 (2 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... 2 µM Dorsomorphin (Tocris), 10 µM SB-431542 (Tocris) ...
-
bioRxiv - Cancer Biology 2024Quote: ... AKTi-1/2 (Tocris), MK-2206 (VWR) ...
-
bioRxiv - Cancer Biology 2020Quote: ... cells were stained with the 4,4-difluoro-1,3,5,7,8-Pentamethy-4-Bora-3a,4a-Diaza-s-indacene (BODIPY) 493/503 dye (Tocris Bio-Techne).
-
bioRxiv - Molecular Biology 2024Quote: ... Ogt deletion was induced by exposing Ogt iKO mESC to 1 μM 4-hydroxytamoxifen (4-OHT) (TOCRIS, 3412). At the time points used in this study (6 days after 4-OHT treatment) ...
-
bioRxiv - Cell Biology 2020Quote: ... 4 µM TCS JNK 60 (Tocris 3222); 5 µM XAV939 (Sigma-Aldrich X3004) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 4-AP (1 mM, Tocris Bioscience), as was done previously (Carta et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... or MRS2211 (4 hours, 50 μM, Tocris) were used to inhibit the microglial purinergic receptors P2Y12R and P2Y12R/P2Y13R respectively ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by 100 µM 4-aminopyridine (Tocris). To rule out contributions from other low latency excitatory receptors ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4-octyl itaconate (Tocris Bioscience, 6662).
-
bioRxiv - Neuroscience 2023Quote: ... and 50 µM 4-AP (Tocris Bioscience). All solutions were continuously bubbled with 95% O2-5% CO2 with pH 7.3-7.4 and 300-310 mOsm ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 µM 4-OH-TMX (Tocris Bioscience) was added to sustain knockout efficiency ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... and 4-DAMP were purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... and 4-aminopyridine (100 μM; Tocris, U.K.) to isolate monosynaptic responses ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... slices were incubated in recording ACSF supplemented with 5 μM 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris, 1045) and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Developmental Biology 2021Quote: ... N2B27 medium was supplemented with CHIR99021 (3 μM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 3 μM CHIR99021 (Tocris Bioscience, Cat N° 4423) for 2 days with medium changes every day (=day 0-1) ...
-
bioRxiv - Cell Biology 2021Quote: ... 3 μM of p38 MAPK inhibitor SB203580 (Tocris, #1202) or NLRP3 inflammasome inhibitor MCC950 (1uM ...
-
bioRxiv - Neuroscience 2020Quote: Clozipine-N-Oxide dihydrochloride (CAS2250025-93-3, Tocris Biosciences) was injected intraperitoneally (i.p. ...
-
bioRxiv - Developmental Biology 2020Quote: ... directly into N2B27 medium containing CHIR99021 (3 µM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Neuroscience 2019Quote: ... and (R)-Baclofen (catalog # 0796, Batch No. 3; Tocris). (±)-Bay K 8644 and Nefiracetam were dissolved in DMSO to a 100 mM stock solution and (R)-Baclofen was dissolved in water (with gentle warming ...
-
bioRxiv - Neuroscience 2022Quote: ... The mGlu2/3 agonist LY379268 was obtained from Tocris (Cat# ...